Letter: Treatment of C.N.S. involvement in systemic lupus erythematosis.
D001925:Brain Damage, Chronic / Q000139:chemically induced*; D001927:Brain Diseases / Q000150:complications / Q000188:drug therapy*; D002648:Child; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy*; D015122:Mercaptopurine / Q000009:adverse effects* / Q000627:therapeutic use
D015122:Mercaptopurine